Stephen F. Carroll
Corporate Officer/Principal bij Lypro Biosciences, Inc.
Profiel
Stephen F.
Carroll is currently the Director of Discovery & Development at Lypro Biosciences, Inc. He previously worked as a Member at XOMA (US) LLC and as an Assistant Professor of Microbiology & Genetics at Harvard Medical School.
Actieve functies van Stephen F. Carroll
| Bedrijven | Functie | Begin |
|---|---|---|
Lypro Biosciences, Inc.
 Lypro Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lypro Biosciences Inc. operates as a therapeutic development company whose proprietary drug delivery nanotechnology increases the solubility and bioavailability of hydrophobic drugs and other therapeutic compounds and facilitates targeting to specific receptor. Its product pipeline includes therapies for infectious diseases such as aspergillosis and leishmaniasis, as well as for cancer such as mantle cell lymphoma. The company was founded by Michael Oda, Murray P Brozinsky and Robert O. Ryan in 2004 and is headquartered in Berkeley, CA. | Corporate Officer/Principal | - |
Eerdere bekende functies van Stephen F. Carroll
| Bedrijven | Functie | Einde |
|---|---|---|
XOMA (US) LLC
 XOMA (US) LLC Pharmaceuticals: MajorHealth Technology XOMA (US) LLC develops pharmaceutical preparations. It offers proprietary drugs and toiletries. The company is headquartered in Emeryville, CA. | Corporate Officer/Principal | - |
| Harvard Medical School | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Lypro Biosciences, Inc.
Lypro Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lypro Biosciences Inc. operates as a therapeutic development company whose proprietary drug delivery nanotechnology increases the solubility and bioavailability of hydrophobic drugs and other therapeutic compounds and facilitates targeting to specific receptor. Its product pipeline includes therapies for infectious diseases such as aspergillosis and leishmaniasis, as well as for cancer such as mantle cell lymphoma. The company was founded by Michael Oda, Murray P Brozinsky and Robert O. Ryan in 2004 and is headquartered in Berkeley, CA. | Health Technology |
XOMA (US) LLC
XOMA (US) LLC Pharmaceuticals: MajorHealth Technology XOMA (US) LLC develops pharmaceutical preparations. It offers proprietary drugs and toiletries. The company is headquartered in Emeryville, CA. | Health Technology |
